...
首页> 外文期刊>PLoS Medicine >A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program
【24h】

A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program

机译:印度预防同伴支持的2型糖尿病生活方式干预:喀拉拉邦糖尿病预防计划的一项集群随机对照试验

获取原文
           

摘要

Background The major efficacy trials on diabetes prevention have used resource-intensive approaches to identify high-risk individuals and deliver lifestyle interventions. Such strategies are not feasible for wider implementation in low- and middle-income countries (LMICs). We aimed to evaluate the effectiveness of a peer-support lifestyle intervention in preventing type 2 diabetes among high-risk individuals identified on the basis of a simple diabetes risk score. Methods and findings The Kerala Diabetes Prevention Program was a cluster-randomized controlled trial conducted in 60 polling areas (clusters) of Neyyattinkara taluk (subdistrict) in Trivandrum district, Kerala state, India. Participants (age 30–60 years) were those with an Indian Diabetes Risk Score (IDRS) ≥60 and were free of diabetes on an oral glucose tolerance test (OGTT). A total of 1,007 participants (47.2% female) were enrolled (507 in the control group and 500 in the intervention group). Participants from intervention clusters participated in a 12-month community-based peer-support program comprising 15 group sessions (12 of which were led by trained lay peer leaders) and a range of community activities to support lifestyle change. Participants from control clusters received an education booklet with lifestyle change advice. The primary outcome was the incidence of diabetes at 24 months, diagnosed by an annual OGTT. Secondary outcomes were behavioral, clinical, and biochemical characteristics and health-related quality of life (HRQoL). A total of 964 (95.7%) participants were followed up at 24 months. Baseline characteristics of clusters and participants were similar between the study groups. After a median follow-up of 24 months, diabetes developed in 17.1% (79/463) of control participants and 14.9% (68/456) of intervention participants (relative risk [RR] 0.88, 95% CI 0.66–1.16, p = 0.36). At 24 months, compared with the control group, intervention participants had a greater reduction in IDRS score (mean difference: ?1.50 points, p = 0.022) and alcohol use (RR 0.77, p = 0.018) and a greater increase in fruit and vegetable intake (≥5 servings/day) (RR 1.83, p = 0.008) and physical functioning score of the HRQoL scale (mean difference: 3.9 score, p = 0.016). The cost of delivering the peer-support intervention was US$22.5 per participant. There were no adverse events related to the intervention. We did not adjust for multiple comparisons, which may have increased the overall type I error rate. Conclusions A low-cost community-based peer-support lifestyle intervention resulted in a nonsignificant reduction in diabetes incidence in this high-risk population at 24 months. However, there were significant improvements in some cardiovascular risk factors and physical functioning score of the HRQoL scale. Trial registration Australia and New Zealand Clinical Trials Registry ACTRN12611000262909 .
机译:背景技术预防糖尿病的主要功效试验已使用资源密集型方法来识别高危人群并提供生活方式干预措施。这样的战略对于在低收入和中等收入国家(LMIC)广泛实施是不可行的。我们旨在评估基于简单糖尿病风险评分而确定的高风险人群中同伴支持的生活方式干预措施在预防2型糖尿病中的有效性。方法和调查结果喀拉拉邦糖尿病预防计划是在印度喀拉拉邦特里凡得琅地区的Neyyattinkara taluk(街道)的60个投票区(集群)中进行的一项集群随机对照试验。参与者(年龄30-60岁)是印度糖尿病风险评分(IDRS)≥60且经口服糖耐量测试(OGTT)未患有糖尿病的参与者。共有1,007名参与者(女性占47.2%)(对照组为507名,干预组为500名)。干预小组的参与者参加了一个为期12个月的基于社区的同伴支持计划,该计划包括15个小组会议(其中12个由受过训练的非专业同伴领导)和一系列社区活动以支持生活方式的改变。控制集群的参与者收到了一本有关生活方式改变建议的教育手册。主要结局是每年OGTT诊断的24个月糖尿病的发生率。次要结果是行为,临床和生化特征以及与健康相关的生活质量(HRQoL)。在24个月内,总共964名参与者(95.7%)得到了随访。研究组之间的群体和参与者的基线特征相似。中位随访24个月后,对照组的参与者患糖尿病的比例为17.1%(79/463),干预组的参与者患糖尿病的比例为14.9%(68/456)(相对危险度[RR] 0.88,95%CI 0.66-1.16,p = 0.36)。与对照组相比,在24个月时,干预参与者的IDRS得分(平均差异:≤1.50分,p = 0.022)和饮酒的减少幅度更大(RR 0.77,p = 0.018),水果和蔬菜的增加幅度更大摄入量(≥5份/天)(RR 1.83,p = 0.008)和HRQoL量表的身体机能评分(平均差异:3.9分,p = 0.016)。提供同伴支持干预的成本为每位参与者22.5美元。没有与干预有关的不良事件。我们没有针对多个比较进行调整,这可能会增加整体I类错误率。结论低成本的基于社区的同伴支持的生活方式干预导致该高危人群在24个月时糖尿病的发生率无明显降低。但是,HRQoL量表的某些心血管危险因素和身体功能评分有显着改善。试验注册澳大利亚和新西兰临床试验注册中心ACTRN12611000262909。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号